Matches in Nanopublications for { ?s ?p "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1157589.RAUDEbXigyPkgtXbamfhG-I_OuAsZqs9PF6c7DihNOFfk130_assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157589.RAUDEbXigyPkgtXbamfhG-I_OuAsZqs9PF6c7DihNOFfk130_provenance.
- NP312647.RAAuswKPiMiYH8Tqe8fcNvI4Abxo6tTj0CNB9_bx1O6pY130_assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312647.RAAuswKPiMiYH8Tqe8fcNvI4Abxo6tTj0CNB9_bx1O6pY130_provenance.
- NP1157591.RABd6XW89d2ZOCtrVkMa7jVvuOPpysu9pLgVKZ-113QbM130_assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157591.RABd6XW89d2ZOCtrVkMa7jVvuOPpysu9pLgVKZ-113QbM130_provenance.
- NP1157587.RAhhcGc8CDnjQJpALwUm9-Ox6zmcDIbGsaUyU120mhAwI130_assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157587.RAhhcGc8CDnjQJpALwUm9-Ox6zmcDIbGsaUyU120mhAwI130_provenance.
- NP1157590.RAnzb3N0R8JXwi73tI4uI62QG7UFCzLy1I5_hTZk6PVKk130_assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157590.RAnzb3N0R8JXwi73tI4uI62QG7UFCzLy1I5_hTZk6PVKk130_provenance.
- NP312641.RANp_KRqP2WmxH1GNa9W8WHSwFYq5-jNNUv1Fb2rRReDw130_assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP312641.RANp_KRqP2WmxH1GNa9W8WHSwFYq5-jNNUv1Fb2rRReDw130_provenance.
- NP1157584.RA-GliHumYr400V-Q9pGFsAhcy9GRXmpRDwEZUNgbanc4130_assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157584.RA-GliHumYr400V-Q9pGFsAhcy9GRXmpRDwEZUNgbanc4130_provenance.
- NP1157585.RA6wnvKm5bASG8TXGLnGik9izwusZypInCICBMTSEIDZk130_assertion description "[Mutual exclusivity of SPOP mutation with ERG rearrangement as well as a high association with CHD1 deletion reinforces SPOP mutation as defining a distinct molecular subclass of prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1157585.RA6wnvKm5bASG8TXGLnGik9izwusZypInCICBMTSEIDZk130_provenance.